Vimian Group AB (publ) (OTCMKTS:VIMGF) Short Interest Update

Vimian Group AB (publ) (OTCMKTS:VIMGF) was the target of a significant drop in short interest in the month of September. As of September 15th, there was short interest totalling 582,700 shares, a drop of 58.8% from the August 31st total of 1,413,100 shares. Based on an average daily volume of 900 shares, the short-interest ratio is presently 647.4 days.

Vimian Group AB (publ) Price Performance

Shares of VIMGF opened at C$4.12 on Friday. The firm has a fifty day moving average price of C$3.42 and a 200-day moving average price of C$2.86. Vimian Group AB has a 12-month low of C$2.68 and a 12-month high of C$4.12.

About Vimian Group AB (publ)

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name.